Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ochs

Showing results (381-390 of 541) with videos related to

Pageof 55
Sort By:
Blood|June 1, 1978
Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivorsD R Noel, R P Witherspoon, R Storb, et al.
Annals of Surgery|April 5, 2000
Sequential cytokine therapy for pressure ulcers: clinical and mechanistic responseM C Robson, D P Hill, P D Smith, et al.
Blood|July 1, 1985
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitroJ M Harlan, P D Killen, F M Senecal, et al.
American Journal of Human Genetics|March 1, 1985
Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndromeU Francke, H D Ochs, B de Martinville, et al.
Journal of Clinical Immunology|February 26, 2017
Gastrointestinal Manifestations in X-linked AgammaglobulinemiaSara Barmettler, Iris M Otani, Jasmit Minhas, et al.
Nature Genetics|January 4, 2001
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3C L Bennett, J Christie, F Ramsdell, et al.
FEBS Letters|August 18, 1997
Missense mutations affecting a conserved cysteine pair in the TH domain of BtkM Vihinen, B F Nore, P T Mattsson, et al.
European Journal of Immunology|August 14, 2001
Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccineM Pérez-Melgosa, H D Ochs, P S Linsley, et al.
Journal of Clinical Immunology|September 5, 2015
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of AgeNiraj C Patel, Joel L Gallagher, Hans D Ochs, et al.
Immunotherapy|August 9, 2018
Intravenous immunoglobulin 10% in children with primary immunodeficiency diseasesHans D Ochs, Isaac Melamed, Michael Borte, et al.
Pageof 55

Showing results (381-390 of 541) with videos related to

Sort By:
Pageof 55
Blood|June 1, 1978
Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivorsD R Noel, R P Witherspoon, R Storb, et al.
Annals of Surgery|April 5, 2000
Sequential cytokine therapy for pressure ulcers: clinical and mechanistic responseM C Robson, D P Hill, P D Smith, et al.
Blood|July 1, 1985
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitroJ M Harlan, P D Killen, F M Senecal, et al.
American Journal of Human Genetics|March 1, 1985
Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndromeU Francke, H D Ochs, B de Martinville, et al.
Journal of Clinical Immunology|February 26, 2017
Gastrointestinal Manifestations in X-linked AgammaglobulinemiaSara Barmettler, Iris M Otani, Jasmit Minhas, et al.
Nature Genetics|January 4, 2001
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3C L Bennett, J Christie, F Ramsdell, et al.
FEBS Letters|August 18, 1997
Missense mutations affecting a conserved cysteine pair in the TH domain of BtkM Vihinen, B F Nore, P T Mattsson, et al.
European Journal of Immunology|August 14, 2001
Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccineM Pérez-Melgosa, H D Ochs, P S Linsley, et al.
Journal of Clinical Immunology|September 5, 2015
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of AgeNiraj C Patel, Joel L Gallagher, Hans D Ochs, et al.
Immunotherapy|August 9, 2018
Intravenous immunoglobulin 10% in children with primary immunodeficiency diseasesHans D Ochs, Isaac Melamed, Michael Borte, et al.
Pageof 55